Literature DB >> 12409822

Oxidative stress and the pathogenesis of muscular dystrophies.

Thomas A Rando1.   

Abstract

The muscular dystrophies represent a diverse group of diseases differing in underlying genetic basis, age of onset, mode of inheritance, and severity of progression, but they share certain common pathologic features. Most prominent among these features is the necrotic degeneration of muscle fibers. Although the genetic basis of many of the dystrophies has been known for over a decade and new disease genes continue to be discovered, the pathogenetic mechanisms leading to muscle cell death in the dystrophies remain a mystery. This review focuses on the oxidative stress theory, which states that the final common pathway of muscle cell death in these diseases involves oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409822     DOI: 10.1097/00002060-200211001-00018

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  39 in total

1.  An initial blueprint for myogenic differentiation.

Authors:  Alexandre Blais; Mary Tsikitis; Diego Acosta-Alvear; Roded Sharan; Yuval Kluger; Brian David Dynlacht
Journal:  Genes Dev       Date:  2005-02-10       Impact factor: 11.361

2.  p21(Cip1) expression is increased in ambient oxygen, compared to estimated physiological (5%) levels in rat muscle precursor cell culture.

Authors:  S J Lees; T E Childs; F W Booth
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

3.  The role of proteases in excitation-contraction coupling failure in muscular dystrophy.

Authors:  Davi A G Mázala; Robert W Grange; Eva R Chin
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-08       Impact factor: 4.249

Review 4.  Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy.

Authors:  Jong-Hee Kim; Hyo-Bum Kwak; LaDora V Thompson; John M Lawler
Journal:  J Muscle Res Cell Motil       Date:  2012-10-28       Impact factor: 2.698

5.  Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.

Authors:  Jose R Lopez; A Uryash; J Kolster; E Estève; R Zhang; J A Adams
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

6.  Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Gavin J Pinniger; Jessica R Terrill; Evanna B Assan; Miranda D Grounds; Peter G Arthur
Journal:  J Physiol       Date:  2017-09-30       Impact factor: 5.182

7.  Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy.

Authors:  Saskia Lassche; Ger J M Stienen; Tom C Irving; Silvère M van der Maarel; Nicol C Voermans; George W Padberg; Henk Granzier; Baziel G M van Engelen; Coen A C Ottenheijm
Journal:  Neurology       Date:  2013-01-30       Impact factor: 9.910

Review 8.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

9.  (-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle.

Authors:  Israel Ramirez-Sanchez; Sergio De los Santos; Silvia Gonzalez-Basurto; Patricia Canto; Patricia Mendoza-Lorenzo; Carlos Palma-Flores; Guillermo Ceballos-Reyes; Francisco Villarreal; Alejandro Zentella-Dehesa; Ramon Coral-Vazquez
Journal:  FEBS J       Date:  2014-10-30       Impact factor: 5.542

Review 10.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.